Official website of the International Senology Oncology Scientific Community
Editor-in-chief: Dr. Gian Paolo Andreoletti - Oncologist, Science Journalist
Prostate Cancer
LINKS
M.D. Anderson Cancer
Center: Prostate cancer
Memorial Sloan-Kettering
Cancer Center: Prostate cancer
National
Cancer Institute: Prostate cancer
American
Urological Association
American Foundation for Urologic Disease:
Prostate cancer
The European Prostate Cancer Coalition
The New England Journal of Medicin
Collections: Prostate
British Medical Journal Collections: Prostate
cancer
The Journal of
the American Medical Association Collections: Prostate cancer
Prostate
Cancer and Prostatic Disease
European
Randomised Study of Screening for Prostate Cancer
LITERATURE SELECTION
PRESS RELEASES
"Approval
of prostate cancer immunotherapy marks milestone in new era of cancer
treatments" - Dana-Farber
Cancer Institute, Boston, MA, USA - www.dana-farber.org
"Studies Presented at 2010 Genitourinary
Cancers Symposium Advance Management, Treatment of Prostate and Bladder
Cancers" - American Society of Clinical Oncology - ASCO -
www.asco.org
"Active surveillance is a viable option for many
men with low risk prostate cancer" - The National Comprehensive
Cancer Network, USA, www.nccn.org
"Vaccine approach extends life of metastatic
prostate cancer patients" - Dana-Farber Cancer Institute, Boston, MA, USA
- www.dana-farber.org
"Experts
at M. D. Anderson Recommend Men Track their PSA Score Over Time" - The
University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA - www.mdanderson.org
"Research
explains how advanced prostate cancer becomes resistant to
androgen-deprivation therapy - Findings suggest androgen production occurs
within metastatic prostate tumors" - Fred Hutchinson Cancer Research Center, Seattle,
WA, USA - www.fhcrc.org
"When
to wait and when to treat? New program will search for biomarkers in men
with prostate cancer to help find an answer" - Fred Hutchinson Cancer Research
Center, Seattle, WA, USA - www.fhcrc.org
"Sometimes No Treatment is the Right Option
for Low-Risk Prostate Cancer. New Study to Explore if Low-Risk Patients
Can Avoid or Postpone Therapy Safely and Effectively" -
University of Texas, M. D. Anderson Cancer Center, Houston, TX
CLINICAL GUIDELINES
"NCCN Guidelines for Prostate Cancer Updated to
Stress Careful Consideration of Active Surveillance" -
The National Comprehensive Cancer Network, USA - www.nccn.org
"NCCN Stresses Importance of PSA Testing in
High-Risk Men" - The National Comprehensive Cancer Network, USA - www.nccn.org
"Prostate cancer: Full guidance" - NICE - National Institute For Clinical Excellence,
London, UK - www.nice.org.uk
NEWS
Red meat and prostate cancer
Statin use and PSA Statin use and PSA - Journal
of the National Cancer Institute - By lowering PSA levels, statins
may complicate prostate cancer detection
Androgen deprivation therapy, localized prostate cancer
and cardiovascular mortality
Androgen deprivation therapy, localized prostate
cancer and cardiovascular mortality - l Journal of the National
Cancer Institute
Prostate cancer therapy and penile lenght
Prostate cancer therapy and penile lenght -
Journal of Urology
EDITORIALS
Focal therapy for localized prostate cancer-
M Zeeshan Aslam - Department of Urology, Churchill Hospital, Headington, Oxford, UK
Magnetic
resonance imaging in patients with a raised PSA and a negative biopsy -
Nathan Lawrentschuk and Neil Fleshner
Adding bicalutamide 150 mg to radiotherapy significantly extends survival
in men with locally advanced prostate cancer -
William A. See
Radical
prostatectomy for locally advanced prostate cancer - Eric Klein
Chronic intraprostatic inflammation may lead to a
greater risk of developing prostate cancer - Sanjay Gupta
Androgen deprivation therapy for prostate cancer is
associated with an increased incidence of diabetes and cardiovascular
disease -
Nancy L. Keating
Radical prostatectomy for locally advanced prostate
cancer - Eric Klein
Bone mineral density changes in prostate cancer
patients on androgen deprivation therapy - Juan Morote
Outcomes and survival in older men with localized
prostate cancer - Richard M. Hoffman
Genitofemoral nerve grafting after radical
prostatectomy and erectile function - Joseph Smith
Androgen Deprivation Therapy as Primary Treatment for
Men with Localized Prostate Cancer - Jun Kawakami
Non-hormonal systemic therapies for the treatment of
men with hormone-refractory prostate cancer and clinical evidence of
metastases - Eric Winquist
Chemoprevention of Prostate Cancer -
Saverio Bettuzzi
The usefulness of PSA screening among healthy men -
John Concato
Prostate cancer patients and potential differences in
outcomes according to the duration of androgen deprivation therapy -
Eric Berthelet
Prostate cancer in men with PSA values below 4.0 ng/ml
is common in a screening population - Alexandre E. Pelzer
Prostate brachytherapy and possibility of continued
fertility - Joe Grocela
Familial and Hereditary Prostate Cancer -
Emilio Sacco
